VB
Vikas Bhardwaj
Medical Technologist, AIIMS New Delhi
Updated: Apr 17, 2026
**Core Concept**
The underlying principle being tested is the pathophysiology of **Androgen Insensitivity Syndrome (AIS)**, previously known as testicular feminization syndrome. This condition is characterized by a **46XY genotype** with resistance to **androgen** action, leading to the development of female external genitalia despite the presence of testes.
**Why the Correct Answer is Right**
Since the correct answer options are not provided, we will focus on the typical presentation of AIS. In individuals with AIS, the presence of testes during fetal development leads to the production of **anti-Müllerian hormone (AMH)**, which inhibits the development of the Müllerian ducts, resulting in the absence of the upper vagina, uterus, and fallopian tubes. However, the lack of androgen response due to **androgen receptor** dysfunction prevents the normal masculinization of external genitalia, leading to a female appearance.
**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, we can infer that any choice suggesting the presence of female internal genitalia (e.g., uterus, fallopian tubes) would be incorrect due to the effect of AMH.
**Option B:** Similarly, any option implying normal androgen sensitivity or male external genitalia development would be incorrect.
**Option C:** An option suggesting the absence of testes or AMH effect would not align with the clinical findings.
**Option D:** Without specifics, we can deduce that any option not consistent with the pathophysiology of AIS would be incorrect.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that individuals with complete AIS typically have a **normal female external appearance**, a **short, blind-ending vagina**, and **testes** often located in the **labia or inguinal canals**.
**Correct Answer:** Correct Answer: D. Presence of testes producing Müllerian inhibiting substance.